This course has expired. View available courses.
Endocrinology
Type 2 Diabetes (T2D): Evaluating Emerging Insulin Therapies – QI&CPD – Category 2
The availability of new insulin therapies has led to new opportunities in the management of type 2 diabetes (T2D), with insulin analogues and combinations demonstrating evidence-based improvements in hypoglycaemia, weight change, and cardiovascular risk factors/outcomes. This module examines two newer insulin therapies: the first is premixed basal insulin plus rapid acting insulin (RAI combination), and the second is single-injection fixed-ratio combinations of basal insulin plus glucagon-like peptide-1 (GLP-1) receptor agonist (Note that these are not yet available in Australia). As hypoglycaemia is a major obstacle for patients with T2D to achieve glycaemic targets, this module will focus on the effects of newer insulin therapies on hypoglycaemia.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
2
ACCREDITATION
QI & CPD - Category 2
EXPIRY DATE
2020-06-29
The availability of new insulin therapies has led to new opportunities in the management of type 2 diabetes (T2D), with insulin analogues and combinations demonstrating evidence-based improvements in hypoglycaemia, weight change, and cardiovascular risk factors/outcomes. This module examines two newer insulin therapies: the first is premixed basal insulin plus rapid acting insulin (RAI combination), and the second is single-injection fixed-ratio combinations of basal insulin plus glucagon-like peptide-1 (GLP-1) receptor agonist (Note that these are not yet available in Australia). As hypoglycaemia is a major obstacle for patients with T2D to achieve glycaemic targets, this module will focus on the effects of newer insulin therapies on hypoglycaemia.
Faculty
Associate Professor Michael d'Emden
MBBS, PhD, FRACP
Director of Endocrinology and Diabetes
Royal Brisbane Hospital
Queensland, Australia)
John Eric Barlow
MBBS, MRACGP
Clinical Supervisor, University of Notre Dame, NSW
Surgical Assistant Strathfield Private Hospital, NSW
Westmead Private Hospital, NSW
Accreditation
#
of credits: 2
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
